Elligo expands research network with oncology center partnership

By Maggie Lynch

- Last updated on GMT

(Image: Getty/LewisTsePuiLung)
(Image: Getty/LewisTsePuiLung)

Related tags Elligo Health Research Clinical research Research Clinical trial Partnership Breast cancer Oncology

Elligo expands its Research Ready network and adds its first oncology practice through a partnership with Austin Cancer Center, which is currently enrolling patients for breast cancer studies.

The health research organization, Elligo, will work with the Austin Cancer Center (ACC) to add its clinical research network,while ACC’s oncologists will offer research as a care option.

Mary Costello, VP of clinic development and patient advocacy at Elligo told us, “Most research starts at academic medical centers and standalone research dedicated practices. By partnering with health care providers in the community, Elligo helps extend access and expand the reach of the study itself.”

According to ACC, the partnership enables its patients to remain under its care while receiving opportunities to participate in clinical studies through Elligo’s Research Ready network. The network operates on its Goes Direct approach connecting patients and sites to research studies across the industry.

Costello said Elligo selected to work with physicians in Austin, TX, the 11th​ largest city in the US, “to allow cancer patients the opportunity to access clinical research in their own community, which increases the likelihood they will participate and extends the chance to participate to all patients, not just those fortunate enough to be able to travel outside of their community.”

ACC currently offers clinical care across medical oncology, comprehensive breast care and breast oncology, gynecologic oncology, radiation oncology, neuro-oncology, and diagnostic and interventional radiology specialties.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us

Products

View more

Webinars